Suspension formulation of interferon

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060263433A1
SERIAL NO

11347109

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A suspension formulation of interferon includes a non-aqueous, single-phase vehicle including at least one polymer and at least one solvent, the vehicle exhibiting viscous fluid characteristics, and an interferon contained in a particle formulation dispersed in the vehicle. The particle formulation includes a stabilizing component comprising one or more stabilizers selected from the group consisting of carbohydrates, antioxidants, and amino acids. The suspension formulation is characterized in that less than 10% of the interferon degrades over 3 months under an accelerated storage condition.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INTARCIA THERAPEUTICS INCONE MARIANA PARK DRIVE SUITE 1300 BOSTON MA 02110

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ayer, Rupal A Cupertino, CA 13 579
Dennis, Paula Auburn, CA 2 143
Desjardin, Michael A Sunnyvale, CA 49 1856
Lam, Stan Dublin, CA 23 996
Liu, Kui Redwood City, CA 50 495
Matsuura, James E Fort Collins, CO 6 196
Narayanan, Latha Milpitas, CA 2 143
Rohloff, Catherine M Los Altos, CA 28 1247
Zamora, Pauline C Sausalito, CA 15 844

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation